7
Views
3
CrossRef citations to date
0
Altmetric
Review

Costs associated with attention deficit hyperactivity disorder: overview and future projections

&
Pages 201-210 | Published online: 09 Jan 2014

References

  • World Health Organization. The ICD- 10 classification of mental and behavioural disorders: diagnostic criteria for research. WHO, Geneva. (1993).
  • Green M, Wong M, Atkins D, Taylor J, Feinleib M. Diagnosis of Attention Deficit Hyperactivity Disonlec Agency for Healthcare Policy and Research, Rockville, MD, USA. Technical Review No. 3. AHCPR Publication No. 99–0050, August (1999).
  • •Technical paper on the prevalence of and utility of screening tests for the diagnosis of attention deficit hyperactivity disorder (ADHD).
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., American Psychiatric Association, Washington, DC, USA (1994).
  • Elia J, Ambrosini P, Rapoport J. Treatment of attention deficit hyperactivity disorder. N Engl. Med. 340(10), 780–788 (1999).
  • Swanson J, Sergeant J, Taylor E etal Attention deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351(9100), 429–433 (1998).
  • Leung P, Luk S, Ho T etal. The diagnosis and prevalence of hyperactivity in Chinese schoolboys. Brit. PFhiatry168, 486–496 (1996).
  • Satin M, Winsberg B, Monetti C etal. A general population screen for attention deficit disorder with hyperactivity. J: Am. Acad. Child Adolesc. fiychiatry24, 756–764 (1985).
  • Scahill L, Schwab-Stone M. Epidemiology of ADHD in school-age children. Child Adolesc. PTchiatc Clin. N Am. 9(3), 541–555 (2000).
  • Conners C. A teacher rating scale for use in drug studies with children. Am. J. Psychiatry 126, 884–888 (1969)
  • •Showcase article for the Conners Rating Scale.
  • Rutter M. A children's behaviour questionnaire for completion by teachers: preliminary findings. J. Child Ptychol fiychiatry Allied Discip. 8(1), 1–11 (1967).
  • •Showcase article for the Rutter's Rating Scale. irConners C. Psychological assessment of children with minimal brain dysfunction.Ann. NY Acad. Sc]. 205,283-302 (1973).
  • Conners C. Psychological assessment of children with minimal brain dysfunction. Ann. NY Acad. Sci. 205, 283–302 (1973).
  • Sandberg S. Hyperactivity Disorder of Childhood. Cambridge Monographs in Child and Adolescent Psychiatry, Cambridge University Press, Cambridge, UK, 7–56 (1996).
  • Costello E, Angold A. Scales to assess child and adolescent depression: checklists, screens and nets. J. Am. Acad. Child Adolesc. fiychiatry 27 (6), 726–737 (1988) .
  • Shaffer D, Fisher P, Lucas C eta]. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions and reliability of some common diagnoses. J. Am. Acad. Child Adolesc. Psychiatry 39 (1), 28–38 (2000).
  • Trites R, Laprade K. Evidence for an independent syndrome of hyperactivity. J. Child Psycho'. fiychiatry Allied Discip.24(4), 573–586 (1983).
  • Nichols P, Chen T Minima] Brain Dysfunctions: a Prospective Study. Erlbaum, Hillsdale, NY, USA (1981).
  • McGee R. DSM-III disorders in a large sample of adolescents. J. Am. Acad. Child Adolesc. Psychiatry 29,611–619 (1990).
  • Anderson J, Williams S, McGee R eta]. DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population. Arch. Gen. fiychiatry44(1), 69–76 (1987).
  • Bird H, Canino G, Rubio-Stipec M. Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico. Aith. Gen. Psychiatry 45, 1120–1126 (1988).
  • Shaffer D, Fisher P, Dulcan MK et al The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC 2.3): description, acceptability, prevalence rates and performance in the MECA Study. J. Am. Acad. Child Adolesc. Psychiatry 35 (7), 865–877 (1996).
  • Szatmari P, Offord D, Boyle M. Ontario Child Health Study: prevalence of attention deficit disorder with hyperactivity. J. Child fiychol. fiychiatry Allied Discip. 30(2), 219–230 (1989).
  • Kelleher KJ, McInerny TK, Gardner WP, Childs GE, Wasserman RC. Increasing identification of psychosocial problems: 1979–1996. Pediatrics 105(6), 1313–1321 (2000).
  • Robison L, Skaer T, Sclar D et al Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants. CNS Drugs 16(2), 129–137 (2002).
  • Zito JM, Safer DJ, dosReis S, Magder LS, Garnder JF, Zarin DA. Psychotherapeutic medication patterns for youths with attention deficit hyperactivity disorder. Arch. Pecliatr Adolesc. Med. 153(12), 1257–1263 (1999).
  • Palfrey J, Singer J, Walker D etal Early identification of children's special needs: a study in five metropolitan communities. J. Pecliatr 111,651–659 (1987).
  • Dobos A, Dworkin P, Bernstein B. Pediatricians' approaches to developmental problems: has the gap been narrowed? J. Dev. Behav. Pecliatr 15,34–39 (1994).
  • Shatin D, Drinkard C. Ambulatory use of psychotropics by employer-insured children and adolescents in a national managed care organization. Arnbu/atoryPediatE 2(2), 111–119 (2002).
  • Cuffe S, Waller J, Cuccaro M eta]. Race and gender differences in the treatment of psychiatric disorders in young adolescents. J. Am. Acad. Child Adolesc. Psychiatry 34, 1536–1543 (1996).
  • Cuffe S, Waller J, Addy C eta] A longitudinal study of adolescent mental health service use. J. Behav. Health Serv. Res. 28,1–11 (2001).
  • Bussing R, Zima BT, Perwien AR, Belin TR, Widawski M. Children in special education programs: attention deficit hyperactivity disorder, use of services and unmet needs. Am. J. Public Health 88(6), 880–886 (1998).
  • •Study used school data to estimate special education service use associated with ADHD.
  • Zito J, Safer D, dosReis S eta]. Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland. J. Am Acad. Child Adolesc. Ptychiatry37, 179–184 (1998).
  • Liebson CL, Katusic SK, Barbaresi WJ, Ransom J, O'Brien PC. Use and costs of medical care for children and adolescents with and without attention deficit hyperactivity disorder. JAMA 285,60–66 (2001).
  • ••Landmark paper on healthcare costsassociated with ADHD.
  • Chan E, Zhan C, Homer CJ. Healthcare use and costs for children with attention deficit hyperactivity disorder: national estimates from the Medical Expenditure Panel Survey. Arch. Pecliatr Adolesc. Med. 156(5), 504–511 (2002).
  • ••Used nationally representative data toinform ADHD expenditures.
  • Guevara J, Lozano P, Wickizer T, Mell L, Gephart H. Utilization and cost of healthcare services for children with attention deficit hyperactivity disorder. Pediatrics 108(1), 71–78 (2001).
  • ••Used data from a large HMO in westernWashington state to estimate healthcare costs associated with ADHD.
  • Kelleher KJ, Childs GE, Harman JS. Healthcare costs for children with attention deficit hyperactivity disorder. Ten. 3(4), 60–63 (2001).
  • ••Used medicaid data from westernPennsylvania to estimate costs for ADHD.
  • Mandell D, Guevara J, Rostain A, Hadley T Medical expenditures among children diagnosed with psychiatric disorders in a Medicaid population. Ptychiatr Serv. (In Press).
  • Szatmari P, Offord DR, Boyle MET. Correlates, associated impairments and patterns of service utilization of children with attention deficit disorder: findings from the Ontario Child Health Study. J. Child Ptychol Ptychiatry30(2), 205–217 (1989).
  • Hoagwood K, Kelleher KJ, Feil M, Comer DM. Treatment services for children with ADHD: a national perspective. J. Am. Acad. Child Adolesc. Psychiatry39(2), 198–206 (2000).
  • Stein B, Orlando M. ADHD treatment in a behavioral healthcare carve-out: medications, providers and service utilization. J. Behav Health Serv. Res. 28 (1), 30–41 (2001).
  • Leslie DL, Rosenheck RA, Horwitz SM. Patterns of mental health utilization and costs among children in a privately insured population. Health Serv. Res. 36(1), 113–127 (2001).
  • •Used private insurance data to show trends in mental health costs.
  • Goldman L, Genel M, Bezman R, Slanetz P Diagnosis and treatment of attention deficit hyperactivity disorder in children and adolescents. JAIVIA 279(14), 1100–1107 (1998).
  • Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R. The treatment of attention deficit hyperactivity disorder. Evidence Report/Technology Assessment No. 11, Agency for Healthcare Research andQuality, Rockville, MD. AHRQ Publication No. 00-E005 (November 1999).
  • •Technical report on evidence-based treatment of ADHD.
  • American Academy of Pediatrics. Clinical Practice Guideline: Diagnosis and Evaluation of the Child with Attention Deficit Hyperactivity Disorder. Pediatrics 105(5), 1158–70 (2000).
  • Guevara J, Lozano P, Wickizer T, Mell L, Gephart H. Psychotropic medication use in a population of children who have attention deficit hyperactivity disorder. Pediatrics 109 (5), 733–739 (2002) .
  • Zito J, Safer D, dosReis S, Gardner J, Boles M, Lynch E Trends in the prescribing of psychotropic medications to preschoolers. JAIVIA 283(8), 1025–1030 (2000).
  • Rappley MD, Mullan PB, Alvarez FJ, Eneli IU, Wang J, Gardiner JC. Diagnosis of attention deficit hyperactivity disorder and use of psychotropic medication in very young children. Arch. Pediatr Adolesc. Med. 153(10), 1039–1045 (1999).
  • Rushton JL, Whitmire JT. Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends. Arch. Pediatr Adolesc. Med. 155, 560–565 (2001).
  • Michelson D, Fades D, Wernicke J, Kelsey D, Kendrick K, Sallee FR eta]. Atomoxetine in the treatment of children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics 108 (5), 83 (2001) .
  • Gilmore A, Milne R. Methylphenidate in children with hyperactivity: review and cost-utility analysis. Phalmaco. Drug- Safety 10,85–94 (2001).
  • Marchetti A, Magar R, Lau H, Murphy EL, Jensen PS, Conners CK etal Pharmacotherapies for attention deficit hyperacivity disorder: expected cost analysis. Ther 23,1904-1921 (2001). SiChan E. The role of complementary and alternative medicine in attention deficit hyperactivity disorder. j Dev. fkhav. Pediatr 23, S37—S45 (2002).
  • Stubberfield TG, Wray JA, Parry TS. Utilization of alternative therapies in attention deficit hyperactivity disorder. Paediatr Child Health 35,450–453 (1999).
  • Chan E, Gardiner P, Kemper KJ. At least its natural: herbs and dietary supplements in ADHD. Contemp. Pediatr 17(9), 116–130 (2000).
  • US Department of Education. Twenty- second annual report to congress on the implementation of the Individuals with Disabilities Education Act, Bureau of Special Education, Jessup, MD, USA. (2000).
  • Office of Special Education Programs. Children with ADD/ADHD - topic brief, US Department of Education, Washington, DC, USA. (1999).
  • Koenning G, Todaro A, Benjamin J, Curry M, Spraul G, Mayer M. Health services delivery to students with special healthcare needs in Texas public schools. j Sch. Health 65(4), 119–123 (1995).
  • Legislative Office of Educational Oversight. Ohio students identified as other health handicapped, Department of Education, Columbus, OH, USA. (2002).
  • Garland A, Hough R, McCabe K eta]. Prevalence of psychiatric disorders in youths across five sectors of care. j Am. Acad. Child Adolesc. PTchiatry 40(4), 409–418 (2001).
  • Teplin L, Abram K, McClelland G et al Psychiatric disorders in youth in juvenile detention. Arch. Gen. Psychiatry 59, 1133–1143 (2002). Landmark study on the prevalence of psychiatric disorders among incarcerated youth.
  • Stern K. A treatment study of children with attention deficit hyperactivity disorder. Office of Juvenile Justice and Delinquency, Washington, DC, USA. (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.